Sudden Sensorineural Hearing Loss - Steroid Therapy

Key Points

• Sudden sensorineural hearing loss is an otologic urgency because treatment benefit is most plausible early in the course.
• Distinguish conductive from sensorineural loss with otoscopy, bedside tuning-fork testing, and prompt audiometry.
• Obtain audiometric confirmation as soon as possible and preferably within 14 days.
• Systemic corticosteroids may be offered within two weeks after individualized risk-benefit discussion.
• Intratympanic corticosteroids are recommended as salvage therapy when recovery is incomplete two to six weeks after onset.
• Hyperbaric oxygen may be considered with steroids in selected patients, including salvage within approximately one month.
• Do not routinely prescribe antivirals or vasodilators for idiopathic SSNHL.
• Evaluate for retrocochlear pathology with MRI or an appropriate alternative rather than routine CT.

Algorithm

1. Confirm that the complaint is truly sudden and examine the ear for conductive causes.
2. Use Weber and Rinne testing when formal audiometry is not immediately available.
3. Identify neurologic red flags or bilateral disease that require broader urgent evaluation.
4. Arrange audiometry promptly to document the degree and pattern of sensorineural loss.
5. Discuss early corticosteroid therapy when within the treatment window and no contraindication outweighs potential benefit.
6. Arrange MRI of the internal auditory canals and brain or alternative retrocochlear evaluation.
7. Recheck hearing after treatment; offer intratympanic salvage therapy for incomplete recovery in the recommended window.
8. Provide hearing rehabilitation and long-term otology follow-up for persistent loss.

Clinical Synopsis & Reasoning

Sudden sensorineural hearing loss (SSNHL) often presents as abrupt unilateral hearing loss noticed on awakening, during a telephone call, or with a sensation of ear fullness. Tinnitus and vertigo may accompany the loss. The first clinical task is to distinguish sensorineural loss from common conductive causes such as cerumen impaction, otitis media, or tympanic membrane disease. Otoscopy should be performed carefully, and bedside tuning-fork testing can help when audiometry is not immediately available. In unilateral sensorineural loss, Weber generally lateralizes to the better ear and Rinne remains air greater than bone on the affected side.

The guideline definition commonly used in research is a loss of at least 30 dB over three contiguous frequencies occurring within 72 hours, but clinicians should not delay evaluation when a patient has a clearly sudden subjectively significant loss that has not yet been audiometrically quantified. Obtain formal audiometry as soon as possible, ideally within 14 days of symptom onset. Ask about neurologic symptoms, severe headache, trauma, barotrauma, autoimmune disease, ototoxic medications, recent infection, fluctuating prior hearing loss, and bilateral symptoms. Focal neurologic deficits, severe gait dysfunction, or other posterior circulation features warrant urgent neurologic evaluation rather than assuming idiopathic SSNHL.

Most cases are idiopathic. Routine broad laboratory panels are low yield, and routine head CT is not recommended solely for SSNHL. Retrocochlear pathology should be evaluated with MRI of the internal auditory canals and brain or, when MRI cannot be performed, an appropriate alternative such as auditory brainstem response testing. Explain that early treatment is time-sensitive but that spontaneous partial recovery can occur, making follow-up audiometry important for both prognosis and treatment decisions.

Treatment Strategy & Disposition

Systemic corticosteroids may be offered as initial therapy within two weeks of symptom onset after discussion of potential benefit, uncertainty, and patient-specific risks. A common adult regimen is prednisone approximately 1 mg/kg daily up to 60 mg for a limited course followed by a taper, but dosing varies by otology practice and should account for diabetes, infection risk, psychiatric history, gastrointestinal disease, and other contraindications. Intratympanic corticosteroid injection is an alternative when systemic steroids are undesirable and is recommended as salvage therapy for incomplete recovery two to six weeks after onset.

Hyperbaric oxygen therapy may be offered in combination with steroids within two weeks of onset or as salvage therapy within approximately one month for selected patients where available. It should not delay corticosteroid treatment or specialist evaluation. Routine antivirals, thrombolytics, vasodilators, vasoactive substances, or other unproven pharmacologic therapies are not recommended for idiopathic SSNHL.

Arrange prompt otolaryngology and audiology follow-up. Repeat audiometry after treatment and again within several months to document recovery and identify persistent disability. Patients with incomplete recovery should receive counseling about hearing rehabilitation, including hearing aids, assistive devices, or cochlear implantation assessment when severe permanent loss persists. Sudden bilateral loss, recurrent episodes, or systemic autoimmune findings require broader evaluation because the probability of an identifiable underlying disorder is higher.

Epidemiology / Risk Factors

• SSNHL most often occurs in middle-aged and older adults but can affect any age group.
• Most cases remain idiopathic after standard evaluation.
• Tinnitus and aural fullness are common associated symptoms, while vertigo is present in a subset and may predict a less favorable prognosis.
• Spontaneous recovery occurs in some patients, particularly with milder initial loss, but cannot be reliably predicted at presentation.

Investigations

Initial Tests

Pharmacology

Prognosis / Complications

• Milder losses and early improvement are associated with better hearing recovery.
• Profound initial loss, advanced age, and associated vertigo are generally associated with worse recovery.
• Some patients have permanent unilateral hearing impairment despite timely treatment.
• Persistent deficits can be mitigated with hearing aids, contralateral routing devices, or cochlear implant evaluation depending on severity.

Patient Education / Counseling

• Explain that the condition is different from a blocked ear and that treatment is time-sensitive even when the ear looks normal.
• Discuss potential steroid adverse effects and the uncertainty of individual treatment response.
• Return immediately for new weakness, diplopia, severe imbalance, severe headache, or other neurologic symptoms.
• Attend audiology and ENT follow-up even if hearing seems to improve.
• Protect the unaffected ear from excessive noise and seek prompt care for any future sudden change in hearing.

Notes

SSNHL is frequently misclassified as congestion because the tympanic membrane can look normal and the patient describes pressure or fullness. A brief tuning-fork examination can prevent this delay. When bedside findings suggest sensorineural loss, treat the complaint as time-sensitive and arrange audiometry and otology care.

The evidence for corticosteroids is imperfect, which is why current guidance frames systemic steroids as an option rather than a guaranteed therapy. Shared decision-making should address the treatment window, severity of hearing loss, comorbidities, and potential steroid harms. Salvage intratympanic treatment is more strongly emphasized for patients who have incomplete recovery.

Routine antivirals and vasodilators persist in some older practice patterns but are not recommended for idiopathic SSNHL. The diagnostic workup should also avoid low-yield scattershot testing. The highest-value tests are those that establish the hearing pattern, detect neurologic emergencies, and exclude retrocochlear disease.

References

1. AAO-HNS Clinical Practice Guideline: Sudden Hearing Loss (Update) — Link
2. AAO-HNS Bulletin: Sudden Hearing Loss Guideline Update — Link
3. NIDCD: Sudden Sensorineural Hearing Loss — Link